Daily SignalsNeutral
2482 companies scored · 2026-10-14 run in progress: 3971 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D
Distribution of the day's forecasts
30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
67 companies
Sorted by 30D forecast ↓
| Ticker | Rating | 30D | Δ |
|---|---|---|---|
| ADMAADMA BIOLOGICS, INC. | +1.11% | · | |
| AQSTAquestive Therapeutics, Inc. | +1.11% | · | |
| PTGXProtagonist Therapeutics, Inc | +1.11% | · | |
| DBVTDBV Technologies S.A. | +1.10% | · | |
| PEPGPepGen Inc. | +1.10% | ▼ 1 | |
| XTLBXTL BIOPHARMACEUTICALS LTD | +1.10% | ▼ 1 | |
| ALKSAlkermes plc. | +1.09% | · | |
| AMRNAMARIN CORP PLC\UK | +1.09% | · | |
| SNDXSyndax Pharmaceuticals Inc | +1.09% | · | |
| ENTAENANTA PHARMACEUTICALS INC | +1.08% | · | |
| OMEROMEROS CORP | +1.08% | · | |
| RIGLRIGEL PHARMACEUTICALS INC | +1.08% | · | |
| SMMTSummit Therapeutics Inc. | +1.08% | · | |
| VNDAVanda Pharmaceuticals Inc. | +1.08% | · | |
| PTCTPTC THERAPEUTICS, INC. | +1.07% | · | |
| ELTPELITE PHARMACEUTICALS INC /NV/ | +1.06% | · | |
| EXELEXELIXIS, INC. | +1.06% | · | |
| GALTGALECTIN THERAPEUTICS INC | +1.06% | · | |
| BCRXBIOCRYST PHARMACEUTICALS INC | +1.05% | · | |
| TARSTarsus Pharmaceuticals, Inc. | +1.05% | · | |
| CANFCan-Fite BioPharma Ltd. | +1.04% | ▼ 1 | |
| NBPNovaBridge Biosciences | +1.04% | · | |
| SIGASIGA TECHNOLOGIES INC | +1.04% | · | |
| CGENCOMPUGEN LTD | +1.02% | · | |
| ZBIOZenas BioPharma, Inc. | +1.02% | · | |
| HALOHALOZYME THERAPEUTICS, INC. | +1.01% | · | |
| IMCRImmunocore Holdings plc | +1.01% | · | |
| PHATPhathom Pharmaceuticals, Inc. | +1.01% | · | |
| AMRXAmneal Pharmaceuticals, Inc. | +0.99% | · | |
| HRMYHarmony Biosciences Holdings, Inc. | +0.99% | · | |
| LENZLENZ Therapeutics, Inc. | +0.98% | · | |
| ALNYALNYLAM PHARMACEUTICALS, INC. | +0.97% | · | |
| NATRNATURES SUNSHINE PRODUCTS INC | +0.97% | · | |
| AXSMAxsome Therapeutics, Inc. | +0.96% | · | |
| GILDGILEAD SCIENCES, INC. | +0.96% | · | |
| NRIXNurix Therapeutics, Inc. | +0.96% | · | |
| ELANElanco Animal Health Inc | +0.95% | · | |
| MSLESatellos Bioscience Inc. | +0.95% | · | |
| CYTKCYTOKINETICS INC | +0.93% | · | |
| LFCRLIFECORE BIOMEDICAL, INC. \DE\ | +0.93% | · | |
| QUREuniQure N.V. | +0.93% | · | |
| CRVSCorvus Pharmaceuticals, Inc. | +0.92% | · | |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | +0.90% | · | |
| ORMPORAMED PHARMACEUTICALS INC. | +0.90% | · | |
| TLRYTilray Brands, Inc. | +0.90% | · | |
| BMRNBIOMARIN PHARMACEUTICAL INC | +0.89% | · | |
| CGCCanopy Growth Corp | +0.88% | · | |
| KODKodiak Sciences Inc. | +0.88% | · | |
| PCRXPacira BioSciences, Inc. | +0.87% | · | |
| ANABANAPTYSBIO, INC | +0.85% | · |
By sector
Median 30D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.